Inhibikase Therapeutics Inc (IKT)

Other Income/Expenses (Net)

$1.46M

Quarterly · Period ending: · USD

IKT logo

IKT Other Income/Expenses (Net)

Latest reported$1.46M
IKT Quarterly Other Income/Expenses (Net) (-$6.35K → $1.46M)
High-resolution chart · PNG

IKT other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
1,459,764
1,834,433
1,040,975
838,093
916,755
919,271
796,123
49,410
90,927
132,725
225,625
173,677
424,435
237,171
55,922
18,536
0
-5
-158
-157
-7,811
-11,797
-7,139
-6,890
-7,948
-7,425
-7,747
-7,812
-5,606
-3,670
-5,627
-11,915
-9,280
-6,354
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.